Atenolol as initial antihypertensive therapy: An observational study comparing first-line agents

Journal of Hypertension

Volumn 25, Issue 7, 2007, Pages 1499-1505

  Blackburn, David F ^a   Lamb, Darcy A ^a   Eurich, Dean T ^c   Johnson, Jeffrey A ^c   Wilson, Thomas W ^b   Dobson, Roy T ^a   Blackburn, James L ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Atenolol; Epidemiology; Hypertension; Pharmacoepidemiology

Indexed keywords

ATENOLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 34250318084     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328136bd21     Document Type: Article

References (16)

1. Canadian Hypertension Education Program (CHEP). The 2006 Canadian recommendations for the management of hypertension. Available at: http://www.hypertension.ca/CHEP2006/CHEP_06_BookletFullText_va.pdf. Accessed 1 August 2006.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289:2560-2571.
3. Beevers DG. The end of beta blockers for uncomplicated hypertension? Lancet 2005; 366:1510-1512.
4. McDougall C, Brady AJB, Petrie JR. ASCOT: a tale of two treatment regimens. BMJ 2005; 331:859-860.
5. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366:1545-1553.
6. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
7. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield MJ, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906.
8. Williams B, Lacy PS, Thom SM, Cruikshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation 2006; 113:1213-1225.
9. Fyhrquist F, Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, et al. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy. Hypertension 2005; 45:580-585.
10. Mayor S. NICE removes beta blockers as first line treatment for hypertension. BMJ 2006; 333:8.
11. Downey W, Stang MR, Beck P, Osei W, Nichol J. Health services databases in Saskatchewan. In: Strom BL, editor. Pharmacoepidemiology, 4th ed. Chichester: Wiley; 2005. pp. 295-310.
12. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 2005; 21:485-488.
13. Von Korf M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45:197-203.
14. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.
15. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. Can Med Assoc J 2006; 174:1737-1742.
16. Messerli HF, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?: a systematic review. JAMA 1998; 279:1903-1907.